Providence, Rhode Island-based University Orthopedics has announced the addition of Thomas Barrett, M.D., a fellowship-trained adult reconstructive surgeon, to its team of orthopedic surgeons.
Thomas Barrett, M.D. Joins University Orthopedics

Dr. Barrett “performs first-time and revision replacements of the hip and knee, including partial knee replacements. He is also skilled in performing an arthroscopy of the knee for the treatment of torn cartilage. University Orthopedics includes more than 40 board certified, fellowship trained musculoskeletal and sports medicine physicians.”
“Over the course of his career, Dr. Barrett has demonstrated a high level of commitment to the orthopedic profession and to Rhode Island patients by participating in the surgical treatment of hundreds of patients in need of care. His devotion to helping patients return to their regular lifestyles will be an asset to University Orthopedics,” said Dr. Edward Akelman, M.D., president of University Orthopedics.
Dr. Barrett is a published author, having written extensively on orthopedic surgery and has also presented his research nationally.
“Dr. Barrett earned his medical degree at Albany Medical College and then remained at that institution for his orthopedic residency. He later completed a fellowship in adult reconstructive orthopedics at the Baylor College of Medicine. In 2016, Dr. Barrett was named an Emerging Leader in Orthopaedics by the American Orthopaedic Association.”
Dr. Barrett commented to OTW, “I am both excited and proud to join such a dedicated and talented group of surgeons and educators. I hope to help expand access to care for those suffering with arthritis, improve efficiency and continue to provide top level care for our community.”

Discussion
This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?
Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.
We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.
Join the conversation
Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.